Sincerely,. James E. Hoyes. President and Head of US Operations. EMD Serono, Inc. Message from James E. Hoyes, President, EMD Serono, Inc. .... TOP SPECIALTY PHARMACY MANAGEMENT PRIORITIES. ACROSS ALL LINES. OF BUSINESS. AVERAGE ASP-BASED REIMBURSEMENT. 40% 40%. 36%. 31%.
May 8, 2017 ... EMD Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical group. Neurodegenerative diseases, fertility and metabolic ... As of 2014, we have helped about 2 million patients through all of our support services: • MS LifeLines • Fertility LifeLines
Brian Barry is the Chief Compliance Officer for EMD Serono, Inc. Mr. Barry is responsible for the ongoing development and implementation of the company's comprehensive compliance program and is also a member of the company's leadership team. Prior to his role as Chief Compliance Office, Mr. Barry served as ...
May 11, 2016 ... The complaint alleges that Merck Serono S.A., Genentech Inc., Amgen Inc., Bayer Schering Pharma AG, Bristol-Myers Squibb and a host of other companies put patients at ... John F. Underwood v. Amgen Inc. et al., case number 1:10-cv- 02441, in the U.S. District Court for the Eastern District of New York.
Jun 11, 2014 ... A further objective was to explore, using data on file (Merck Serono Ltd, 2013), whether patients in the ROI were more likely to remain on treatment, compared ... In the ROI, all patients who are treated with sc IFN β-1a collect their medication from a local pharmacy, and are registered to receive MySupport.
Jul 8, 2009 ... Neal R. Platt. Commentary: “Aura” as Quality—A Sumptuary Law for Our Times? Glenn Mitchell. Amicus Brief of the International Trademark Association in. Ferring Pharmaceuticals Inc. v. Watson Pharmaceuticals, Inc. Amicus Brief of the International Trademark Association in. Magasins Best Buy Ltée et al.